X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (79681) 79681
Newsletter (45801) 45801
Publication (5215) 5215
Newspaper Article (3036) 3036
Transcript (396) 396
Book Review (346) 346
Book Chapter (163) 163
Dissertation (155) 155
Magazine Article (142) 142
Conference Proceeding (92) 92
Trade Publication Article (65) 65
Book / eBook (20) 20
Web Resource (11) 11
Data Set (10) 10
Reference (10) 10
Government Document (2) 2
Paper (2) 2
Streaming Video (2) 2
Journal / eJournal (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lung cancer, non-small cell (79840) 79840
cancer (51870) 51870
humans (48602) 48602
research (45194) 45194
care and treatment (31287) 31287
oncology (29829) 29829
oncology, experimental (28762) 28762
index medicus (28000) 28000
female (26884) 26884
male (26824) 26824
lung neoplasms - pathology (23086) 23086
middle aged (22985) 22985
aged (22192) 22192
lung cancer (21537) 21537
carcinoma, non-small-cell lung - pathology (21035) 21035
chemotherapy (19047) 19047
lung cancer, small cell (18994) 18994
carcinoma, non-small-cell lung - drug therapy (17734) 17734
lung neoplasms - drug therapy (17371) 17371
non-small cell lung cancer (15986) 15986
reports (15745) 15745
prognosis (15696) 15696
adult (14035) 14035
genetic aspects (12190) 12190
analysis (11785) 11785
carcinoma, non-small-cell lung - genetics (11237) 11237
metastasis (11206) 11206
lung neoplasms - genetics (11150) 11150
neoplasm staging (10774) 10774
respiratory system (9894) 9894
tumors (9255) 9255
aged, 80 and over (9214) 9214
lung neoplasms - mortality (9057) 9057
carcinoma, non-small-cell lung - mortality (8905) 8905
radiotherapy (8525) 8525
universities and colleges (8394) 8394
survival (7987) 7987
treatment outcome (7796) 7796
health aspects (7784) 7784
lung neoplasms - metabolism (7632) 7632
carcinoma, non-small-cell lung - metabolism (7504) 7504
surgery (7457) 7457
carcinoma (7042) 7042
apoptosis (7017) 7017
antineoplastic agents (6950) 6950
medical research (6893) 6893
lung neoplasms - surgery (6879) 6879
carcinoma, non-small-cell lung - surgery (6804) 6804
antimitotic agents (6762) 6762
drug therapy (6685) 6685
antineoplastic combined chemotherapy protocols - therapeutic use (6549) 6549
physical fitness (6398) 6398
mutation (6344) 6344
cell line, tumor (6140) 6140
non-small cell lung carcinoma (6096) 6096
development and progression (5996) 5996
clinical trials (5934) 5934
expression (5917) 5917
retrospective studies (5883) 5883
medicine, experimental (5879) 5879
epidermal growth factor (5783) 5783
survival rate (5403) 5403
biochemistry (5370) 5370
gefitinib (5248) 5248
hematology, oncology and palliative medicine (5159) 5159
antineoplastic agents - therapeutic use (5075) 5075
adenocarcinoma (5065) 5065
animals (5007) 5007
survival analysis (4826) 4826
communicable diseases (4793) 4793
nsclc (4790) 4790
pharmaceutical industry (4712) 4712
carcinoma, non-small-cell lung - radiotherapy (4703) 4703
non-small-cell lung cancer (4605) 4605
lung neoplasms - therapy (4594) 4594
diagnosis (4591) 4591
lung neoplasms - radiotherapy (4573) 4573
carcinoma, non-small-cell lung - therapy (4570) 4570
patient outcomes (4468) 4468
cancer therapies (4424) 4424
cisplatin (4371) 4371
drugs (4332) 4332
immunotherapy (4303) 4303
cell research (4253) 4253
immunohistochemistry (4214) 4214
patients (4143) 4143
gene expression (4123) 4123
therapy (3903) 3903
respiratory tract diseases (3855) 3855
lung neoplasms - diagnosis (3817) 3817
carcinoma, non-small-cell lung - diagnosis (3740) 3740
risk factors (3707) 3707
erlotinib (3694) 3694
cell lung-cancer (3608) 3608
mice (3481) 3481
proteins (3398) 3398
disease-free survival (3391) 3391
radiation (3366) 3366
follow-up studies (3284) 3284
radiology, nuclear medicine & medical imaging (3122) 3122
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (123716) 123716
Chinese (1580) 1580
French (1247) 1247
Japanese (942) 942
German (565) 565
Korean (265) 265
Spanish (234) 234
Polish (227) 227
Russian (162) 162
Turkish (112) 112
Italian (92) 92
Czech (57) 57
Portuguese (52) 52
Hungarian (44) 44
Dutch (20) 20
Bulgarian (16) 16
Romanian (13) 13
Danish (12) 12
Serbian (11) 11
Icelandic (9) 9
Slovak (9) 9
Finnish (8) 8
Lithuanian (8) 8
Croatian (6) 6
Norwegian (6) 6
Hebrew (5) 5
Swedish (5) 5
Belarusian (1) 1
Bosnian (1) 1
Persian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 21, pp. 1976 - 1986
Journal Article
2005, Hematology/oncology clinics of North America, ISBN 9781416027737, Volume 19, no. 2., xii, p. 209-426
Book
Chest, ISSN 0012-3692, 2016, Volume 151, Issue 1, pp. 193 - 203
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2014, Volume 371, Issue 23, pp. 2167 - 2177
The ALK inhibitor crizotinib as first-line therapy was associated with a significantly better response rate, longer progression-free survival, and greater... 
CRITERIA | MEDICINE, GENERAL & INTERNAL | GEFITINIB | THERAPY | CISPLATIN | ADENOCARCINOMA | PHASE-III | KINASE | ANAPLASTIC LYMPHOMA | QLQ-C30 | PLUS | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Guanine - analogs & derivatives | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Cisplatin - administration & dosage | Pyridines - adverse effects | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Pyrazoles - adverse effects | Pyridines - therapeutic use | Kaplan-Meier Estimate | Carboplatin - administration & dosage | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Pemetrexed | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Glutamates - administration & dosage | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Adenocarcinoma - mortality | Guanine - administration & dosage | Appetite | Edema | Inhibitor drugs | Intravenous administration | Biomedical research | Lung cancer | Diarrhea | Non-small cell lung carcinoma | Fatigue | Nausea | Metastasis | Patients | Cisplatin | Quality of life | Chemotherapy | Lungs | Platinum | Vomiting | Comparative studies | Carboplatin
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2013, Volume 8, Issue 3, p. e60317
Aberrant expression of microRNA-146a (miR-146a) has been reported to be involved in the development and progression of various types of cancers. However, its... 
SUPPRESSOR | ONCOGENESIS | RNA | MULTIDISCIPLINARY SCIENCES | CERVICAL-CANCER | INTERFERENCE | MICRORNAS | NF-KAPPA-B | FACTOR RECEPTOR | EXPRESSION | CONTRIBUTES | Lung Neoplasms - drug therapy | Humans | Lung Neoplasms - metabolism | Middle Aged | Gene Expression Regulation, Neoplastic | Lung Neoplasms - pathology | Male | MicroRNAs - metabolism | NF-kappa B - metabolism | Receptor, Epidermal Growth Factor - metabolism | Antibodies, Monoclonal, Humanized - pharmacology | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacology | Lung - metabolism | Cetuximab | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung - pathology | Signal Transduction | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Lung - drug effects | Cell Line, Tumor | Aged | Cell Proliferation - drug effects | MicroRNAs - genetics | Carcinoma, Non-Small-Cell Lung - drug therapy | Apoptosis | Cell Movement | MicroRNA | Growth | Monoclonal antibodies | Lung cancer, Small cell | Development and progression | Lung cancer, Non-small cell | Health aspects | Cell proliferation | Laboratories | Lung cancer | Oncology | Drug delivery | Kinases | Paraffin | Cancer therapies | Metastases | Signal transduction | Cell growth | Bioindicators | Inhibition | Gefitinib | Sensitizing | NF-κB protein | Phenotypes | Cytokines | Epidermal growth factor receptors | MiRNA | Non-small cell lung carcinoma | siRNA | Breast cancer | Gene expression | Ribonucleic acid--RNA | Patients | Pathology | Signaling | Chemotherapy | Thyroid cancer | MicroRNAs | Medical prognosis | Pancreatic cancer | Cell lines | Biomarkers | Mutation | Cell migration | Cervical cancer | Tumors | Cancer | Ribonucleic acid
Journal Article
Journal Article
Chest, ISSN 0012-3692, 07/2009, Volume 136, Issue 1, pp. 260 - 271
Journal Article